Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Humbert

Showing results (131-140 of 327) with videos related to

Pageof 33
Sort By:
Blood|September 6, 2001
The deubiquitinating enzyme DUB-2 prolongs cytokine-induced signal transducers and activators of transcription activation and suppresses apoptosis following cytokine withdrawalT S Migone, M Humbert, A Rascle, et al.
Thorax|April 30, 2004
Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertensionA Chaouat, F Coulet, C Favre, et al.
Revue Des Maladies Respiratoires|May 1, 2012
[HIV-related pulmonary arterial hypertension]L Savale, F Lador, X Jais, et al.
Revue Medicale Suisse|December 25, 2014
[Vulnerable older patients in primary care how to identify them? Which ressources to mobilize? ]C Smith, E Rubli, N Senn, et al.
The European Respiratory Journal|July 3, 2010
Severe pulmonary hypertension in histiocytosis X: long-term improvement with bosentanL Kiakouama, V Cottin, B Etienne-Mastroïanni, et al.
European Journal of Clinical Investigation|August 22, 2006
Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defectsO Sitbon, M Beghetti, J Petit, et al.
Thorax|April 9, 1999
Urinary cGMP concentrations in severe primary pulmonary hypertensionM Bogdan, M Humbert, J Francoual, et al.
Revue Des Maladies Respiratoires|December 3, 2009
[Asthma: a disease of the whole bronchial tree]I Tillie-Leblond, R Louis, A Magnan, et al.
Allergy|December 17, 2008
Omalizumab therapy: patients who achieve greatest benefit for their asthma experience greatest benefit for rhinitisM Humbert, L P Boulet, R M Niven, et al.
Cellular Immunology|April 15, 1993
Invariant chain expression similarly controls presentation of endogenously synthesized and exogenous antigens by MHC class II moleculesS Lombard-Platet, P Bertolino, C Gimenez, et al.
Pageof 33

Showing results (131-140 of 327) with videos related to

Sort By:
Pageof 33
Blood|September 6, 2001
The deubiquitinating enzyme DUB-2 prolongs cytokine-induced signal transducers and activators of transcription activation and suppresses apoptosis following cytokine withdrawalT S Migone, M Humbert, A Rascle, et al.
Thorax|April 30, 2004
Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertensionA Chaouat, F Coulet, C Favre, et al.
Revue Des Maladies Respiratoires|May 1, 2012
[HIV-related pulmonary arterial hypertension]L Savale, F Lador, X Jais, et al.
Revue Medicale Suisse|December 25, 2014
[Vulnerable older patients in primary care how to identify them? Which ressources to mobilize? ]C Smith, E Rubli, N Senn, et al.
The European Respiratory Journal|July 3, 2010
Severe pulmonary hypertension in histiocytosis X: long-term improvement with bosentanL Kiakouama, V Cottin, B Etienne-Mastroïanni, et al.
European Journal of Clinical Investigation|August 22, 2006
Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defectsO Sitbon, M Beghetti, J Petit, et al.
Thorax|April 9, 1999
Urinary cGMP concentrations in severe primary pulmonary hypertensionM Bogdan, M Humbert, J Francoual, et al.
Revue Des Maladies Respiratoires|December 3, 2009
[Asthma: a disease of the whole bronchial tree]I Tillie-Leblond, R Louis, A Magnan, et al.
Allergy|December 17, 2008
Omalizumab therapy: patients who achieve greatest benefit for their asthma experience greatest benefit for rhinitisM Humbert, L P Boulet, R M Niven, et al.
Cellular Immunology|April 15, 1993
Invariant chain expression similarly controls presentation of endogenously synthesized and exogenous antigens by MHC class II moleculesS Lombard-Platet, P Bertolino, C Gimenez, et al.
Pageof 33